Surgical Aspects of Ovarian/Tubal/Peritoneal Cancer Management
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 55
Special Issue Editors
Interests: vulvar cancer; cervical cancer; gynecologic cancers
Special Issues, Collections and Topics in MDPI journals
Interests: gynecologic oncology; clinical studies on vulvar and cervical cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit an article for a special edition of Cancers entitled ‘Surgical Aspects of Ovarian/Tubal/Peritoneal Cancer Management’. Although most ovarian cancers are epithelial in origin, surgical management of other histological types, including germ ccell tumours, would also be acceptable. Surgical staging, fertility sparing surgery, primary cytoreduction, interterval cytoreduction, and secondary cytoreduction are all topics of interest. One of the most controversail issues in the management of patients with advanced ovarian cancer at the present time is the role of neoadjuvamt chemotherapy (NACT). There is no doubt that NACT has helped to decrease the morbidity of cytoreductive surgery in properly selected patients. However, many are concerned that it is presently being used too frequently, and hence more evidence to better define the role of NACT would be welcome. In addition to papers on survival after various surgical interventions, articles on imaging to better identify suitable patients, the morbidity of particular operations, and the quality of life after surgical management would all be acceptable topics. Although prospective studies are primarily desirable, large retrospective studies or review articles would also be acceptable.
You may choose our Joint Special Issue in Diseases.
Prof. Dr. Neville F. Hacker
Dr. Jacobus van der Velden
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- primary cytoreduction
- interval cytoreduction
- neoadjuvant chemotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
